Edition:
United States

Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

60.32EUR
9:37am EST
Change (% chg)

€-1.14 (-1.85%)
Prev Close
€61.46
Open
€60.86
Day's High
€60.98
Day's Low
€59.90
Volume
675,700
Avg. Vol
924,757
52-wk High
€93.82
52-wk Low
€59.90

Latest Key Developments (Source: Significant Developments)

Fresenius Medical Care Acquires Renal Hospitals And Dialysis Centers In China
Wednesday, 5 Dec 2018 05:36am EST 

Dec 5 (Reuters) - Fresenius Medical Care AG & Co KGaA ::CARE ANNOUNCES ACQUISITION OF RENAL HOSPITALS AND DIALYSIS CENTERS IN CHINA.COMPANY ACQUIRED A 70% SHARE OF GUANGZHOU KANGNIDAISI MEDICAL INVESTMENT CO., LTD,.ALSO ACQUIRED 55% STAKES IN HENAN AISHEN AND AISHEN BEIJING.  Full Article

Fresenius Medical Care Net Income Down 8 Pct
Tuesday, 30 Oct 2018 02:19am EDT 

Oct 30 (Reuters) - Fresenius Medical Care : :REVENUE IN THE THIRD QUARTER 2018 DECREASED BY 6% TO EUR 4,058 MILLION.REVENUE IN THE THIRD QUARTER 2018 DECREASED BY 6% TO EUR 4,058 MILLION (-6% AT CONSTANT CURRENCY).HEALTH CARE SERVICES REVENUE DECREASED BY 8% TO EUR 3,258 MILLION (-8% AT CONSTANT CURRENCY).ON A COMPARABLE BASIS, CARE COORDINATION REVENUE DECLINED BY 22% (-27% AT CONSTANT CURRENCY).IN THE FIRST NINE MONTHS OF 2018, REVENUE DECREASED BY 8% TO EUR 12,247 (-2% AT CONSTANT CURRENCY).TOTAL EBIT REACHED EUR 527 MILLION IN THE THIRD QUARTER OF 2018, A DECREASE OF 13% (-20% AT CONSTANT CURRENCY).THE STRONG DECREASE WAS MAINLY ATTRIBUTABLE TO THE HIGHER COMPARABLE BASE WHICH INCLUDED THE EBIT CONTRIBUTION FROM SOUND OF EUR 20 MILLION.NET INCOME ATTRIBUTABLE TO SHAREHOLDERS OF FRESENIUS MEDICAL CARE AG & CO. KGAA DECREASED BY 8% TO EUR 285 MILLION IN THE THIRD QUARTER OF 2018 (-17% AT CONSTANT CURRENCY).THE COMPANY EXPECTS REVENUE3 GROWTH BETWEEN 2% AND 3% AT CONSTANT CURRENCY IN 2018.NET INCOME ON A COMPARABLE BASIS IS EXPECTED TO INCREASE BY 11% TO 12% AT CONSTANT CURRENCY.GROWTH DID NOT ACCELERATE TO THE EXTENT PREVIOUSLY PROJECTED. WE ANTICIPATE THE IMPACT FROM THE CURRENT LEVEL OF GROWTH AND LESS ACQUISITIONS TO CONTINUE IN THE FOURTH QUARTER. .  Full Article

Fresenius Medical Care To Implement Share Buy-Back Programme
Friday, 25 May 2018 05:17am EDT 

May 25 (Reuters) - FRESENIUS MEDICAL CARE AG & CO KGAA ::WILL IMPLEMENT A SHARE BUY-BACK PROGRAMME.UP TO A MAXIMUM OF 431,000 ORDINARY SHARES WILL BE REPURCHASED AT A TOTAL PURCHASE PRICE OF UP TO 39 MILLION EURO.  Full Article

Fresenius Medical Care Q4 Net Income 394 Mln Euros, Up 16 Pct At Constant Currency
Monday, 26 Feb 2018 04:56pm EST 

Feb 26 (Reuters) - Fresenius Medical Care ::SAYS FOR 2018, CO EXPECTS REVENUE GROWTH OF AROUND 8 PERCENT AT CONSTANT CURRENCY‍​.Q4 REVENUE 4.43 BILLION EUROS, YOY GROWTH 0%‍​.SAYS TARGETS 2017 ACHIEVED‍​.NET INCOME FOR THE FOURTH QUARTER OF 2017 INCREASED BY 16% AT CONSTANT CURRENCY TO EUR 394 MILLION.NET INCOME TO INCREASE 13 TO 15% AT CONSTANT CURRENCY INCLUDING RECURRING BENEFITS FROM U.S. TAX REFORM OF 140 TO 160 MILLION EUROS IN 2018.SAYS Q4 REVENUE GROWTH OF 8% AT CONSTANT CURRENCY.  Full Article

Fresenius Medical sets aside EUR200 mln for U.S. settlement talks
Monday, 26 Feb 2018 04:35pm EST 

Feb 26 (Reuters) - Fresenius Medical Care AG ::SAYS ‍ESTABLISHES PROVISION OF EUR 200 MILLION REGARDING ONGOING FCPA SETTLEMENT NEGOTIATIONS​.SAYS ‍PROVISION TAKES INTO ACCOUNT RECENT DEVELOPMENTS IN ONGOING SETTLEMENT NEGOTIATIONS WITH U.S. DEPARTMENT OF JUSTICE AND U.S. SECURITIES EXCHANGE COMMISSION​.SAYS ‍CHARGE ENCOMPASSES GOVERNMENT AGENCIES' CLAIMS FOR PROFIT DISGORGEMENT, AS WELL AS ACCRUALS FOR FINES AND/OR PENALTIES, CERTAIN LEGAL AND OTHER CONSULTANCY EXPENSES AND OTHER RELATED​.SAYS ‍SETTLEMENT NEGOTIATIONS ARE CONTINUING AND HAVE NOT YET ACHIEVED AN AGREEMENT-IN-PRINCIPLE; FAILURE TO REACH AGREEMENT REMAINS POSSIBLE​.  Full Article

Fresenius Medical Care Closes Divestment Of Shiel Medical Laboratory To Quest Diagnostics
Tuesday, 12 Dec 2017 08:03am EST 

Dec 12 (Reuters) - FRESENIUS MEDICAL CARE AG & CO KGAA ::DGAP-NEWS: FRESENIUS MEDICAL CARE CLOSES DIVESTMENT OF SHIEL MEDICAL LABORATORY TO QUEST DIAGNOSTICS.  Full Article

FMC Q3 impacted by natural disasters in North America
Thursday, 2 Nov 2017 02:00am EDT 

Nov 2 (Reuters) - FMC AG :‍Says Q3 sales up 3 pct at ‍4.336​ billion eur (+8 pct at constant currency).Says Q3 EBIT flat at ‍609​ million eur (+4 pct at constant currency).Says Q3 net income up 2 pct at ‍309 ​million eur.Says North American business impacted by natural disasters.Says ‍excluding effects from natural disasters, effects of agreement with U.S. Departments of Veterans Affairs and Justice, confirms its full-year outlook 2017​​.Says North America Care Coordination activities grow by 20% (+26 pct at constant currency), margin expands significantly to 7 pct​.Says ‍closing of NxStage deal is currently expected to occur in 2018​.Reuters poll average for FMC q3 net revenue was 4.41 billion eur, EBIT 611 million eur, net income 297 million eur.  Full Article

Quest Diagnostics to acquire Shiel Medical Laboratory from Fresenius Medical Care
Thursday, 28 Sep 2017 07:30am EDT 

Sept 28 (Reuters) - Quest Diagnostics Inc :Quest Diagnostics to acquire Shiel Medical Laboratory from Fresenius Medical Care.Quest Diagnostics Inc says financial terms were not disclosed..Says ‍transaction is structured as a purchase of assets.​.Quest Diagnostics Inc says transaction is expected to be completed in Q4 of 2017, subject to customary regulatory approvals.Quest Diagnostics - ‍Fresenius Medical Care's dialysis-related laboratory services business, Spectra Labs, is not affected by divestiture​.  Full Article

Eurotech wins order from Fresenius Medical Care for IoT project​
Friday, 8 Sep 2017 02:01am EDT 

Sept 8 (Reuters) - EUROTECH SPA ::‍DESIGN WIN WITH FRESENIUS MEDICAL CARE <<>> TO SUPPLY HARDWARE AND SOFTWARE BUILDING BLOCKS FOR THEIR IOT PROJECT​.NO FURTHER FINANCIAL DETAILS CAN BE DISCLOSED‍​.  Full Article

NxStage Medical posts Q2 loss of $0.03 per share
Monday, 7 Aug 2017 02:15am EDT 

Aug 7 (Reuters) - Nxstage Medical Inc :NxStage reports second quarter financial results.Q2 revenue $96.2 million versus I/B/E/S view $96.5 million.NxStage Medical - in light of acquisition agreement between Fresenius Medical Care and NxStage, NxStage is no longer providing financial guidance.Has canceled its previously announced conference call to discuss its financial results for Q2 of 2017.Qtrly loss per share $0.03.  Full Article

Germany's Fresenius Medical Care snaps up stakes in Chinese hospitals

BERLIN Germany's Fresenius Medical Care (FMC) has acquired several stakes in Chinese kidney hospitals and dialysis clinics as it seeks to expand in the world's second-biggest market for dialysis by patient numbers.